Meanwhile, ICMT inhibitors impede mTOR-mediated autophagy, disrupt tumor cell cycle progression, and augment anticancer activity [515–518].UCM- 1336 is a new generation of ICMT inhibitors, a promising drug candidate with more potent enzyme inhibition and lower toxicity than cysmethynil [517, 519]. Here, MTOR is linked to neoplasm.